Ph.D. in Experimental Therapeutics
About the Program
Experimental therapeutics is the integration of basic and applied sciences focused on the study of and development of new treatments for human disease. Research in experimental therapeutics seeks to understand human diseases from the molecular level to the whole organism in order to develop rational approaches for new pharmacological treatments. In addition, experimental therapeutics includes the development of new therapies through systematic investigation at increasing levels of complexity ranging from individual molecules and proteins, to cellular and tissue based assays and to the whole organism. The purpose of the program is to train students at the doctoral level who can translate discoveries in the laboratory to therapies in a clinical setting.
About the Curriculum
The curriculum for the Experimental Therapeutics Ph.D. program includes required courses, electives, and a dissertation. Satisfactory overall performance is expected on a written qualifying examination, administered before starting the dissertation research. A grade of B- or higher is expected to be maintained for the required courses. A grade of B- or higher is also required for all of the prerequisite and co-requisite courses. An overall GPA of 3.0 or higher must be maintained.
Funding for graduate students is limited, and when available, it is offered to applicants based on strengths of their credentials compared with the others in the same pool of applications. It is accomplished in one of three (3) ways:
- Teaching Assistantships include a waiver of tuition, but not student fees, and a stipend provided by the graduate school for approximately 20 hours per week of specialized service to the College of Pharmacy and Pharmaceutical Sciences.
- Research Assistantships are offered through research grants.
- Tuition waiver only
Dr. Ezdihar Hassoun, Chair
The University of Toledo College of Pharmacy and Pharmaceutical Sciences
Department of Pharmacology
3000 Arlington Ave.
Toledo, OH 43614